Genworth Financial reports Q1 2026 earnings today against a backdrop of unusually bullish options positioning — a notable divergence from the cautious tone that dominated the stock's options market just weeks ago.
Options traders have rotated decisively toward calls ahead of the print. The put/call ratio has dropped to 0.19, well below its 20-day average of 0.24 and running more than 1.3 standard deviations below that mean. This is close to the most call-heavy the book has been in the past year; the 52-week low on PCR sits at 0.10, meaning the current reading is near the bullish extreme of the annual range. The stock itself closed at $8.87 on Tuesday, up 5.7% over the past month but flat on the day and down around 1.6% on the week.
Short interest is a minor factor in this setup. At 1.8% of the free float — down roughly 10.5% over the past month — there is no meaningful short pressure concentrated heading into results. Borrow costs have ticked up, nearly doubling from their one-month lows to 0.52%, but in absolute terms that remains extremely cheap. Availability in the lending pool is loose, and with short interest at these levels, squeeze dynamics are not a live consideration.
The lone active analyst voice belongs to Keefe, Bruyette & Woods, which reinstated coverage in late March with an Outperform rating and a $10.50 target — roughly 18% above current levels. KBW has steadily ratcheted up its target over the past year, moving from $8.00 to $9.00 to $10.00 before the latest reinstatement. The bull case centres on Genworth's Enact mortgage insurance segment: a 17% market share, projected 2–3% annual growth in insurance in-force, and ROEs of 11–13% in a higher-rate environment. Bears point to a less resolved liability tail — specifically the $850 million AXA settlement for pre-2005 mis-selling — which creates ongoing uncertainty even as the company has reduced gross debt from $2.7 billion to $0.8 billion and bought back $590 million in shares since 2022.
Institutional ownership offers some context on how the stock is held. BlackRock and Vanguard together account for over 26% of shares, with both incrementally adding in the most recent quarter. American Century added 821,904 shares through April 30, a more active build than the index-rebalancing flow seen from the passive giants.
Insider activity from late February is largely noise — the CFO and a divisional CEO sold modest amounts alongside routine equity awards, all at low significance scores. The 90-day net insider position is marginally positive at roughly $1.1 million, but not the kind of concentrated buying that changes the narrative.
Today's earnings release is therefore a test of whether the Enact segment's operating momentum — in-force growth, loss ratios, and capital return cadence — can justify the options market's unusually optimistic lean into the number.
See the live data behind this article on ORTEX.
Open GNW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
